Last reviewed · How we verify
NCT06050057
Surgical Treatment of Adrenal Diseases- Laparoscopic vs. Robotic-assisted Adrenalectomy
trial in Adrenal Tumor in 100 participants. Currently enrolling.
30 June 2024
Quick facts
| Lead sponsor | University Hospital Olomouc |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 100 |
| Start date | 3 September 2023 |
| Primary completion | 30 June 2024 |
| Estimated completion | 30 June 2026 |
| Sites | 1 location across Czechia |
Conditions studied
- Adrenal Tumor — all drugs for Adrenal Tumor →
- Adrenal Disease — all drugs for Adrenal Disease →
- Adrenal Mass — all drugs for Adrenal Mass →
- Adrenalectomy; Status — all drugs for Adrenalectomy; Status →
Sponsor
University Hospital Olomouc
Who can join
18 and older, any sex, with Adrenal Tumor or Adrenal Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this multicenter, observational, analytic, randomized clinical trial is to analyze the laparoscopic and robot-assisted method in the surgical treatment of patients with adrenal diseases. The main question it aims to answer are: 1. to find the superiority of one the the surgical method mentioned above 2. to compare the quality of life in patients with adrenal mass before surgery and after laparoscopic or robotic-assisted adrenalectomy.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06050057
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Adrenal Tumor
Currently open trials in the same condition.
- NCT06520111 — CRISAL Study:Cancer Risk In Secreting Adrenal Lesions · recruiting
- NCT04127552 — Impact of Adrenal IncidenTalomas and Possible Autonomous Cortisol Secretion on Cardiovascular and Metabolic Alterations · recruiting
- NCT04905706 — 3D Laparoscopic Adrenalectomies for Adrenal Tumors · recruiting
Other University Hospital Olomouc trials
Trials by the same sponsor.
- NCT06981026 — The Effectiveness of Telemedicine Monitoring Prehabilitation in Prostate Cancer Patients Undergoing Radical Prostatectom · NA · not yet recruiting
- NCT07360886 — Early Detection of Selected Neuropathologies in Motor Vehicle Drivers · recruiting
- NCT07356076 — The Use of Electrical Impedance Tomography (EIT) in Pulmonary Diseases · recruiting
- NCT07075679 — Screening Mammography: Single Reading by One Radiologist With AI vs. Double Reading by Two Radiologists (AI-BCSQ) · NA · recruiting
- NCT06964425 — Raman Spectroscopy in the Diagnosis of Extrahepatic Cholangiocarcinoma - a Pilot Study · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06050057 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital Olomouc
- Last refreshed: 22 September 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06050057.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing